Webinar: Generation of TCR-mimic antibodies targeting intracellular proteins to expand the druggable target repertoire for anti-tumor therapies

Our webinar “Generation of TCR-mimic antibodies targeting intracellular proteins to expand the druggable target repertoire for anti-tumor therapies” was live at 12:00 PM EST on Nov 14th, 2023. 

About the webinar:

Traditional antibody therapy has been limited to extracellular tumor targets; however, many oncogenic and tumor-associated proteins are intracellular. One strategy to overcome this limitation is to target the pHLA complex mimicking TCR recognition. In this webinar, Dr. W. Frank An will outline the current progress in the field of TCR-mimic(TCRm) antibody discovery, highlighting Biocytogen’s lead TCRm programs, which have generated highly specific antibodies for bispecific engager therapy and TCRm-T cell therapy.

Date and Time

Nov 14, 2023, 12:00 PM EST

Speaker

W. Frank An, PhD.

Sr. Director of Antibody Therapeutics, Biocytogen Institute for Therapeutic Innovations, Biocytogen Pharmaceuticals

Moderator

Jenna Frame, Ph.D.

Sr. Manager, Scientific Communications & Marketing, Biocytogen Boston Corp

Watch the webinar recording on demand: Generation of TCR-mimic antibodies targeting intracellular proteins to expand the druggable target repertoire for anti-tumor therapies

Event Date: Nov 14, 2023, 12:00 PM EST | Event Location: Online